Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert D Cardiff

Showing results (141-150 of 182) with videos related to

Pageof 19
Sort By:
Nature Genetics|April 28, 2009
Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesisJennifer C King, Jin Xu, John Wongvipat, et al.
Cancer Research|May 20, 2004
Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasisSuh-Chin J Lin, Kuo-Fen Lee, Alexander Yu Nikitin, et al.
Breast Cancer Research : BCR|November 11, 2005
Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situRuria Namba, Lawrence J T Young, Jeannie E Maglione, et al.
Cancer Research|May 27, 2010
Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancerAdam C Pond, Jason I Herschkowitz, Kathryn L Schwertfeger, et al.
Oncogene|August 8, 2002
Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumorsKeiko Miyoshi, Andrea Rosner, Masahiro Nozawa, et al.
Cancer Research|April 24, 2013
Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology CommitteeMichael Ittmann, Jiaoti Huang, Enrico Radaelli, et al.
Cancer Research|March 18, 2004
Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology CommitteeScott B Shappell, George V Thomas, Richard L Roberts, et al.
Toxicologic Pathology|November 1, 2006
Precancer in mice: animal models used to understand, prevent, and treat human precancersRobert D Cardiff, Miriam R Anver, Gregory P Boivin, et al.
Breast Cancer Research : BCR|January 24, 2012
STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomasSzeman Ruby Chan, William Vermi, Jingqin Luo, et al.
Toxicologic Pathology|November 3, 2005
Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumorsNicolas Currier, Sandra E Solomon, Elizabeth G Demicco, et al.
Pageof 19

Showing results (141-150 of 182) with videos related to

Sort By:
Pageof 19
Nature Genetics|April 28, 2009
Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesisJennifer C King, Jin Xu, John Wongvipat, et al.
Cancer Research|May 20, 2004
Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasisSuh-Chin J Lin, Kuo-Fen Lee, Alexander Yu Nikitin, et al.
Breast Cancer Research : BCR|November 11, 2005
Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situRuria Namba, Lawrence J T Young, Jeannie E Maglione, et al.
Cancer Research|May 27, 2010
Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancerAdam C Pond, Jason I Herschkowitz, Kathryn L Schwertfeger, et al.
Oncogene|August 8, 2002
Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumorsKeiko Miyoshi, Andrea Rosner, Masahiro Nozawa, et al.
Cancer Research|April 24, 2013
Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology CommitteeMichael Ittmann, Jiaoti Huang, Enrico Radaelli, et al.
Cancer Research|March 18, 2004
Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology CommitteeScott B Shappell, George V Thomas, Richard L Roberts, et al.
Toxicologic Pathology|November 1, 2006
Precancer in mice: animal models used to understand, prevent, and treat human precancersRobert D Cardiff, Miriam R Anver, Gregory P Boivin, et al.
Breast Cancer Research : BCR|January 24, 2012
STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomasSzeman Ruby Chan, William Vermi, Jingqin Luo, et al.
Toxicologic Pathology|November 3, 2005
Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumorsNicolas Currier, Sandra E Solomon, Elizabeth G Demicco, et al.
Pageof 19